TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in Human A549 lung cancer cells

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 205-213

  Ko, Hyeonseok ^b   So, Youngsin ^a   Jeon, Hyelin ^a   Jeong, Mi Hyeon ^a   Choi, Hyo Kyoung ^c   Ryu, Seung Hee ^a   Lee, Sang Wook ^a   Yoon, Ho Geun ^c   Choi, Kyung Chul ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

A549 cells; Acetylation; EGCG; EMT; TGF 1

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EPIGALLOCATECHIN GALLATE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ACETYLATION; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

ACETYLATION; ANTICARCINOGENIC AGENTS; ANTIGENS, CD; CADHERINS; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; P300-CBP TRANSCRIPTION FACTORS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 84878471721     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.018     Document Type: Article

References (36)

1. Thiery J.P. Epithelial-mesenchymal transitions in cancer onset and progression. Bulletin de l'Académie nationale de médecine 2009, 193:1969-1978.
2. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961.
3. Vincent T., Neve E.P., Johnson J.R., Kukalev A., Rojo F., Albanell J., et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat. Cell Biol. 2009, 11:943-950.
4. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 131(7):131-142.
5. Xu J., Lamouille S., Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
6. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62:1613-1618.
7. Roberts A.B., Heine U.I., Flanders K.C., Sporn M.B. Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann. N. Y. Acad. Sci. 1990, 580:225-232.
8. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994, 8:133-146.
9. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
10. Kaimori A., Potter J., Kaimori J.Y., Kaimori J.Y., Wang C., Mezey E., Koteish A. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 2007, 282:22089-22101.
11. Rygiel K.A., Robertson H., Marshall H.L., Pekalski M., Zhao L., Booth T.A., et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab. Invest. 2008, 88(2):112-123.
12. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000, 19:1745-1754.
13. Janknecht R., Wells N.J., Hunter T. TGF-beta-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 1998, 12:2114-2119.
14. Nishihara A., Hanai J.I., Okamoto N., Yanagisawa J., Kato S., Miyazono K., et al. Role of p300, a transcriptional coactivator, in signalling of TGF-beta. Genes to cells: devoted to molecular & cellular mechanisms 1998, 3:613-623.
15. Gray S.G., Teh B.T. Histone acetylation/deacetylation and cancer: an " open" and " shut" case?. Curr. Mol. Med. 2001, 1:401-429.
16. Glozak M.A., Sengupta N., Zhang X., Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
17. Asano Y., Czuwara J., Trojanowska M. Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. J. Biol. Chem. 2007, 282:34672-34683.
18. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5:769-784.
19. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., Ranga U., et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 2004, 279:51163-51171.
20. Balasubramanyam K., Altaf M., Varier R.A., Swaminathan V., Ravindran A., Sadhale P.P., et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 2004, 279:33716-33726.
21. Choi K.C., Jung M.G., Lee Y.H., Yoon J.C., Kwon S.H., Kang H.B., et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009, 69:583-592.
22. Choi K.C., Lee Y.H., Jung M.G., Kwon S.H., Kim M.J., Jun W.J., et al. Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol. Cancer Res. 2009, 7:2011-2021.
23. Kapoor M., Howard R., Hall I., Appleton I. Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats. Am. J. Pathol. 2004, 165:299-307.
24. Zhang Q., Kelly A.P., Wang L., French S.W., Tang X., Duong H.S., et al. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways. J. Invest. Dermatol. 2006, 126:2607-2613.
25. Yoon H.G., Chan D.W., Reynolds A.B., Qin J., Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 2003, 12:723-734.
26. Simonsson M., Kanduri M., Gronroos E., Heldin C.H., Ericsson J. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J. Biol. Chem. 2006, 281:39870-39880.
27. Shook D., Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech. Dev. 2003, 120:1351-1383.
28. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
29. Grunert S., Jechlinger M., Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 2003, 4:657-665.
30. Radisky D.C. Epithelial-mesenchymal transition. J. Cell Sci. 2005, 118:4325-4326.
31. Perez R.E., Navarro A., Rezaiekhaligh M.H., Mabry S.M., Ekekezie I.I. TRIP-1 regulates TGF-beta1-induced epithelial-mesenchymal transition of human lung epithelial cell line A549. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L799-807.
32. Tu A.W., Luo K. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response. J. Biol. Chem. 2007, 282:21187-21196.
33. Inoue Y., Itoh Y., Abe K., Okamoto T., Daitoku H., Fukamizu A., et al. Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene 2007, 26:500-508.
34. Lim J.Y., Oh M.A., Kim W.H., Sohn H.Y., Park S.I. AMP-activated protein kinase inhibits TGF-beta-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J. Cell. Physiol. 2012, 227:1081-1089.
35. Sriram N., Kalayarasan S., Sudhandiran G. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis. Chem. Biol. Interact. 2009, 180:271-280.
36. Hung C.F., Huang T.F., Chiang H.S., Wu W.B. (-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms. J. Cell. Biochem. 2005, 96:183-197.